CALCIMEDICA Trademark

Trademark Overview

On Monday, July 16, 2007, a trademark application was filed for CALCIMEDICA with the United States Patent and Trademark Office. The USPTO has given the CALCIMEDICA trademark a serial number of 77230287. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, April 23, 2021. This trademark is owned by CalciMedica, Inc.. The CALCIMEDICA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases, and for the prevention of organ transplant rejections; small molecule drugs for use in medical therapy, namely, for the treatment of autoimmune and inflammatory diseases, and for the prevention of organ transplant rejections
calcimedica

General Information

Serial Number77230287
Word MarkCALCIMEDICA
Filing DateMonday, July 16, 2007
Status800 - REGISTERED AND RENEWED
Status DateFriday, April 23, 2021
Registration Number4060245
Registration DateTuesday, November 22, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 17, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune and inflammatory diseases, and for the prevention of organ transplant rejections; small molecule drugs for use in medical therapy, namely, for the treatment of autoimmune and inflammatory diseases, and for the prevention of organ transplant rejections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 20, 2007
Primary Code005
First Use Anywhere DateFriday, January 21, 2011
First Use In Commerce DateFriday, January 21, 2011

Trademark Owner History

Party NameCalciMedica, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameCalciMedica, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameCalciMedica, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Monday, November 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 23, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, April 23, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, April 23, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 22, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 11, 2021TEAS SECTION 8 & 9 RECEIVED
Sunday, November 22, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, December 13, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, December 13, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, December 13, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 20, 2017TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 22, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 22, 2011REGISTERED-PRINCIPAL REGISTER
Thursday, October 20, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 19, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, October 17, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 27, 2011STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 8, 2011USE AMENDMENT FILED
Thursday, September 8, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, August 30, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 30, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 10, 2011SOU EXTENSION 5 GRANTED
Friday, March 4, 2011SOU EXTENSION 5 FILED
Friday, March 4, 2011SOU TEAS EXTENSION RECEIVED
Thursday, September 9, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 8, 2010SOU EXTENSION 4 GRANTED
Tuesday, September 7, 2010SOU EXTENSION 4 FILED
Tuesday, September 7, 2010SOU TEAS EXTENSION RECEIVED
Monday, March 15, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 13, 2010SOU EXTENSION 3 GRANTED
Monday, February 8, 2010SOU EXTENSION 3 FILED
Saturday, March 13, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 8, 2010SOU TEAS EXTENSION RECEIVED
Tuesday, September 22, 2009SOU EXTENSION 2 GRANTED
Wednesday, September 2, 2009SOU EXTENSION 2 FILED
Tuesday, September 22, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 2, 2009SOU TEAS EXTENSION RECEIVED
Monday, February 9, 2009SOU EXTENSION 1 GRANTED
Monday, February 9, 2009SOU EXTENSION 1 FILED
Monday, February 9, 2009SOU TEAS EXTENSION RECEIVED
Tuesday, September 9, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 17, 2008PUBLISHED FOR OPPOSITION
Wednesday, May 28, 2008NOTICE OF PUBLICATION
Thursday, May 15, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 9, 2008ASSIGNED TO LIE
Friday, May 9, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 28, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 28, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 28, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 31, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 31, 2007NON-FINAL ACTION E-MAILED
Wednesday, October 31, 2007NON-FINAL ACTION WRITTEN
Friday, October 19, 2007ASSIGNED TO EXAMINER
Friday, July 20, 2007NEW APPLICATION ENTERED

Related Keywords

calcimedica prevention transplant rejections diseases organ inflammatory treatment autoimmune medical therapy